In neurological diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), including other tauopathies, the activation of the NLRP3 inflammasome is triggered by protein aggregates, such as β-amyloid plaques and tau protein fibrils (protein aggregates). This evidence concerns the gene MAPT and Parkinson disease.